Table II.

Numbers of splenic B cell subsets during acute and chronic SCI^a

		Total Cells	TR1	TR2	TR3	FO	MZ
	Un-injuredb	131.6±26.2	2.7±0.6	2.5±0.8	2.3±0.7	28.9±5.4	3.2±0.5
Day 8 Post Injuryc	T9-Lam	138.0±9.2	0.9±0.1*	1.3±0.2*	1.2±0.2*	24.1±3.0	2.9±0.6
	T9-SCI	104.3±15.6*,#	0.6±0.2*	0.9±0.2*	1.0±0.3*	18.3±2.1*	2.3±0.5
	T3-Lam	111.1±22.1	1.5±0.9*	1.6±0.7*	1.6±0.5	21.2±6.5*	3.1±1.9
	T3-SCI	111.3±18.5	0.3±0.1*,#	0.7±0.2*,#	0.7±0.2*,#	20.2±3.9*	2.5±0.5
Day 28 Post Injuryd	T9-Lam	149.7±32.9	3.8±0.8*	2.6±0.4	2.2±0.4	30.4±8.2	3.2±0.7
	T9-SCI	86.8±12.5*,#	2.5±0.6#	2.2±0.6	2.0±0.7	21.1±4.0#	3.4±0.4
	T3-Lam	119±22.2	3.5±0.7	2.5±0.5	2.0±0.4	22.9±4.6	2.9±0.5
	T3-SCI	93.6±24.1*	1.6±0.4*,#	1.8±0.5	1.8±1.0	22.3±5.9	4.3±1.3*,#

^aNumber ± SD of cells (×10⁶) per spleen, representative FACS plots shown in Fig. 2. Figures shown are representative of 3 experiments at each post-injury time point. Data shown has been pooled across 2 experiments for un-injured controls, 1 for laminectomies, and 1 for SCI at each level.

^bn=10 for Un-injured

^cn=8 for T9-Lam, n=6 for T9-SCI, n=8 for T3-Lam, and n=5 for T3, SCI.

^dn=7 for T9-Lam, n=5 for T9-SCI, n=7 for T3-Lam, and n=6 for T3-SCI.

^*Denotes significant difference from un-injured control at p<0.05

^#Denotes significant difference from respective laminectomy control at p<0.05